← Retour à la une
États-Unis · Plateformes & données · MarketBeat

What OptimizeRx (OPRX) Said on Its Q3 Earnings Call

Publié par MarketBeat · États-Unis il y a 59 min
Image from MarketBeat Media, LLC.
Image from MarketBeat Media, LLC. · MarketBeat

Résumé détaillé

OptimizeRx (NASDAQ:OPRX) lowered its 2026 revenue outlook after third-quarter sales fell 17%, even as cost reductions and a favorable product mix helped the healthcare marketing technology company increase profitability. The company now expects full-year revenue of $87 million to $93 million, while

Lire l'article complet sur MarketBeat Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)

À lire aussi

The Motley Fool

Why B&G Foods Stock Soared Today

 MarketWatch

Nvidia’s stock drops as the board reportedly prepares to remove CEO Jensen Huang

 Investing.com

Global electric vehicle sales return to growth in October

 Seeking Alpha

Here are the major earnings before the open Thursday

 CNBC

Prediction markets tied to clinical trials and drug approvals draw lawmakers' ire

 Stocktwits

CoreWeave Reportedly Plans $4B Investment-Grade Loan After Strong Earnings Beat — But Shares Fall After-Hours On Nvidia CEO Drama